Atossa Therapeutics Inc (ATOS)

Atossa Therapeutics Inc Azioni (ATOS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
	11.91%8.69	9.87	11.44	9.25	9.04
Research and Development	2.47%4.90	4.78	6.16	5.37	5.50
Operating Income/Loss	11.91%-8.69	-9.87	-11.44	-9.25	-9.04
Income/Loss From Continuing Operations Before Tax	11.45%-8.49	-9.59	-10.94	-8.69	-8.42
Income Tax Expense/Benefit	-	-	-	-	-
	11.45%-8.49	-9.59	-10.94	-8.69	-8.42
Attributable To Parent	11.45%-8.49	-9.59	-10.94	-8.69	-8.42
Basic Average Shares	3.32%8.91	8.62	-	129.17	129.17
Diluted Average Shares	3.32%8.91	8.62	-	129.17	129.17
Basic Earnings Per Share	14.41%-0.95	-1.11	-	-0.07	-0.07
Diluted Earnings Per Share	14.41%-0.95	-1.11	-	-0.07	-0.07